¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

´ëÇѽÅÀåÇÐȸ KSN(Korea Society of Nephrology) 2022 (1ÀÏÂ÷) : 2022-05-26

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
´ëÇѽÅÀåÇÐȸ KSN(Korea Society of Nephrology) 2022 (1ÀÏÂ÷) : 2022-05-26
±³À°ÀÏÀÚ : 2022-05-26
±³À°Àå¼Ò : ¼­¿ï µå·¡°ï½ÃƼȣÅÚ  
±³À°ÁÖÁ¦ : KSN(Korea Society of Nephrology) 2022 (1ÀÏÂ÷)
ÁÖÃÖ±â°ü : ´ëÇѽÅÀåÇÐȸ
´ã´çÀÚ : ´ëÇѽÅÀåÇÐȸ
¿¬¶ôó : 02-3486-8736  
À̸ÞÀÏ : ksn@ksn.or.kr      
±³À°Á¾·ù : ³»°úÀÇ»çÇÐ
Âü¼®¿¹»óÀοø : 2000¸í
Èñ¸ÁÆòÁ¡ : 6Á¡  
Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 32 ½Ã°£ 0ºÐ  
¼¼ºÎ¼ö°­·á : 200,000¿ø      
ºñ°í ¡áȸ¿ø: »çÀü(100,000)/ÇöÀå(150,000) ¡áºñȸ¿ø: »çÀü(150,000)/ ÇöÀå(200,000) ¡áFellow-in-training,Resident,Trainee,Student,Nurse,etc: »çÀü(50,000)/ ÇöÀå(35,000) *Medical Student: ¸éÁ¦      

±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 05-26 Room 1(5F) 08:30~09:00 Surgical Anatomy and Radiological Imaging of Vascular Access for Hemodialysis  ±è¿¹´Ï(¼­¿ï¼º¸ðº´¿ø) 
±³À°½Ã°£ 05-26 Room 1(5F) 09:00~09:30 Strategies to Improve Patency of Vascular Access  ±¸»ó°Ç(â¿øÇѸ¶À½º´¿ø) 
±³À°½Ã°£ 05-26 Room 1(5F) 09:30~10:00 Assessment of Vascular Access Using Ultrasonography (Live Demonstration)  ±èÀºÁ¤(ÇѸ²´ëÇб³µ¿Åº¼º½Éº´¿ø) 
±³À°½Ã°£ 05-26 Room 1(5F) 10:00~10:30 Practical Aspects of Tunneled Catheter for Maintenance Hemodialysis  È²Çö¼®(°æÈñÀÇ´ë) 
±³À°½Ã°£ 05-26 Room 1(5F) 10:40~11:10 ISPD Peritonitis Guideline: 2022 Update  Philip Li(Chinese University of Hong Kong) 
±³À°½Ã°£ 05-26 Room 1(5F) 11:10~11:40 Volume Control in peritoneal dialysis  °­¿µ¼±(°í·Á´ëÇб³¾È»êº´¿ø) 
±³À°½Ã°£ 05-26 Room 1(5F) 11:40~12:10 Prescribing peritoneal dialysis  ÀåÅÂÀÍ(±¹¹Î°Ç°­º¸Çè°ø´Ü Àϻ꺴¿ø) 
±³À°½Ã°£ 05-26 Room 1(5F) 12:10~12:40 Peritoneal Membrane Dysfunction  À¯ÅÂÇö(¿¬¼¼ÀÇ´ë) 
±³À°½Ã°£ 05-26 Room 1(5F) 13:30~14:10 Propensity Score Matching  ¹Ú¼ÒÈñ(¿¬¼¼´ëÇб³ º¸°Ç´ëÇпø) 
±³À°½Ã°£ 05-26 Room 1(5F) 14:10~14:50 Marginal Structural Models  ÀÓÇö¼±(±¹¹Î°Ç°­º¸Çè°ø´Ü Àϻ꺴¿ø) 
±³À°½Ã°£ 05-26 Room 1(5F) 14:50~15:30 Mendelian Randomization  ¹Ú¼¼ÈÆ(±¹±º¼öµµº´¿ø) 
±³À°½Ã°£ 05-26 Room 1(5F) 15:40~16:10 Increasing of End Stage Renal Disease in Asia  ÇÔ¿µ·Ï(Ãæ³²´ëÇб³º´¿ø) 
±³À°½Ã°£ 05-26 Room 1(5F) 16:10~16:40 Effectiveness of Multidisplinary care in Chronic Kidney Disease management  Pongsathorn Gojaseni(Bhumibol Adulyadej Hospital) 
±³À°½Ã°£ 05-26 Room 1(5F) 16:40~17:10 Challenges and Future Opportunities of Peritoenal Dialysis in Asia  Lily Mushahar(Hospital Tuanku Ja) 
±³À°½Ã°£ 05-26 Room 1(5F) 17:10~17:40 Do Asian Kidney Transplant Recipients Need Different Target Level of Maintenance Immunosuppressants?  Á¤Á¾Ã¶(ºÐ´ç¼­¿ï´ëÇб³º´¿ø) 
±³À°½Ã°£ 05-26 Room 2(3F) 08:30~09:00 Complicated Cases of Hyponatremia  ¹é¼±ÇÏ(ÇѸ²´ëÇб³µ¿Åº¼º½Éº´¿ø) 
±³À°½Ã°£ 05-26 Room 2(3F) 09:00~09:30 Sjogren Syndrome and Renal Tubular Acidosis Type 1  ÃÖÈ«»ó(Àü³²´ëÇб³º´¿ø) 
±³À°½Ã°£ 05-26 Room 2(3F) 09:30~10:00 Hyperkalemia Encountered in RAAS Inhibitor Users  À¯ÅÂÇö(¿¬¼¼ÀÇ´ë) 
±³À°½Ã°£ 05-26 Room 2(3F) 10:00~10:30 Hyperkalemia and Hypomagnensemia in Kidney Transplant Recipients  ±è¿ëö(¼­¿ï´ëº´¿ø) 
±³À°½Ã°£ 05-26 Room 2(3F) 10:40~11:10 Basic Principles of Vascular Access for Hemodialysis  ÀÌÇü¼®(ÇѸ²´ëÇб³¼º½Éº´¿ø) 
±³À°½Ã°£ 05-26 Room 2(3F) 11:10~11:40 The Role of Pocus in Hemodialysis Unit  ±èÀºÁ¤(ÇѸ²´ëÇб³µ¿Åº¼º½Éº´¿ø) 
±³À°½Ã°£ 05-26 Room 2(3F) 11:40~12:10 How to Overcome AV Access Thrombotic Flow-related Complications  ÀÌÁøÈ£(À̽ų»°úÀÇ¿ø) 
±³À°½Ã°£ 05-26 Room 2(3F) 12:10~12:40 How to Overcome AV Access Non-thrombotic Complications  ±¸»ó°Ç(â¿øÇѸ¶À½º´¿ø) 
±³À°½Ã°£ 05-26 Room 2(3F) 13:30~14:00 Longitudinal Blood Pressure Trajectory and Chronic Kidney Disease Progression  ÁÖ¿µ¼ö(¿ëÀμ¼ºê¶õ½ºº´¿ø) 
±³À°½Ã°£ 05-26 Room 2(3F) 14:00~14:30 Cumulative Hypertension Burden and Renal Outcome  ±è⼺(Àü³²´ëÇб³º´¿ø) 
±³À°½Ã°£ 05-26 Room 2(3F) 14:30~15:00 KDIGO Target for Systolic Blood Pressure in Chronic Kidney Disease of  ±èÁ°æ(ÇѸ²´ëÇб³¼º½Éº´¿ø) 
±³À°½Ã°£ 05-26 Room 2(3F) 15:00~15:30 KDIGO Target for Systolic Blood Pressure in Chronic Kidney Disease of  ±è¾ç±Õ(°­µ¿°æÈñ´ëº´¿ø) 
±³À°½Ã°£ 05-26 Room 2+3+4(3F) 18:00~18:50 Food as a Medicine in Chronic Kidney Disease  Peter Stenvinkel(Karolinska Institutet and Karolinska University Hospital) 
±³À°½Ã°£ 05-26 Room 3(3F) 08:30~09:10 Monitoring and Management of New on diabetes after transplantation  ÀÌÁ¤Ç¥(¼­¿ïÀÇ´ë) 
±³À°½Ã°£ 05-26 Room 3(3F) 09:10~09:50 Monitoring and Management of Persistent Hyperparathyroidism After Kidney Transplant  °í°­Áö(°í·ÁÀǴ뱸·Îº´¿ø) 
±³À°½Ã°£ 05-26 Room 3(3F) 09:50~10:30 Cancer Screening Strategy After Kidney Transplant  À¯°æµ·(¿ï»ê´ëÇб³º´¿ø) 
±³À°½Ã°£ 05-26 Room 3(3F) 10:40~11:10 Identification of an A-Kinase Anchor Protein Essential for Urinary Concentration  Fumiaki Ando(Tokyo Medical and Dental University) 
±³À°½Ã°£ 05-26 Room 3(3F) 11:10~11:40 B Cell Repertoire in Lupus Nephritis - Role in Disease Pathogenesis and Implications on Treatment  Desmond Yap(Queen Mary Hospital) 
±³À°½Ã°£ 05-26 Room 3(3F) 11:40~12:10 Acute Kidney Injury and Gut Dysbiosis  ¾çÁöÇö(°í·Á´ëÇб³¾È¾Ïº´¿ø) 
±³À°½Ã°£ 05-26 Room 3(3F) 12:10~12:40 Extracellular Vesicles in Kidney Disease: From Basic Research to Translational Application  Linli Lv(Southeast University School of Medicine) 
±³À°½Ã°£ 05-26 Room 3(3F) 12:40~13:10 Determinants of Gut-derived Uremic Toxins  Ting-Yun Lin(Taipei Tzu Chi Hospital) 
±³À°½Ã°£ 05-26 Room 3(3F) 13:40~14:10 CD68 Immunohistochemistry as a Marker of E Score for IgA Nephropathy Classification  ±è¿ëÁø(°æºÏ´ëº´¿ø) 
±³À°½Ã°£ 05-26 Room 3(3F) 14:10~14:40 Aristolochic Acid Nephropathy  Gang Liu(Peking University) 
±³À°½Ã°£ 05-26 Room 3(3F) 14:40~15:20 Clinical pathological conference: Case of Pediatrics  ¾È¿äÇÑ(¼­¿ï´ëº´¿ø) 
Åä·Ð 05-26 Room 3(3F) 14:40~15:20 Clinical Discussion  ÀÌÁö¿ø(Áúº´°ü¸®Ã») 
±³À°½Ã°£ 05-26 Room 3(3F) 14:40~15:20 Clinical pathological conference: Case of Pathology ¥°  ¹®°æö(¼­¿ï´ëº´¿ø) 
±³À°½Ã°£ 05-26 Room 3(3F) 15:20~16:00 Clinical pathological conference: Case of Internal Medicine ¥°  À¯ÅÂÇö(¿¬¼¼ÀÇ´ë) 
Åä·Ð 05-26 Room 3(3F) 15:20~16:00 Clinical Discussion  ÀÌÁ¤Àº(»ï¼º¼­¿ïº´¿ø) 
±³À°½Ã°£ 05-26 Room 3(3F) 15:20~16:00 Clinical pathological conference: Case of Pathology ¥±  ÀÓ¹üÁø(°­³²¼¼ºê¶õ½ºº´¿ø) 
±³À°½Ã°£ 05-26 Room 3(3F) 16:00~16:40 Clinical pathological conference: Case of Internal Medicine ¥±  ±èÈ¿»ó(¿ï»êÀÇ´ë ¾Æ»êº´¿ø) 
Åä·Ð 05-26 Room 3(3F) 16:00~16:40 Clinical Discussion  ±è¾ç±Õ(°­µ¿°æÈñ´ëº´¿ø) 
±³À°½Ã°£ 05-26 Room 3(3F) 16:00~16:40 Clinical pathological conference: Case of Pathology ¥²  °íÇöÁ¤(¿ï»êÀÇ´ë ¾Æ»êº´¿ø) 
±³À°½Ã°£ 05-26 Room 4(3F) 08:30~08:40 Deep Learning-based Prediction Model for Postoperative AKI in Major Non-cardiac Surgeries  ¹Ú¼¼ÈÆ(±¹±º¼öµµº´¿ø) 
±³À°½Ã°£ 05-26 Room 4(3F) 08:40~08:50 Long Term Outcome of Acute Kidney Injury: New-on Comorbidities and Survival  ¾çÁöÇö(°í·Á´ëÇб³¾È¾Ïº´¿ø) 
±³À°½Ã°£ 05-26 Room 4(3F) 08:50~09:00 Platelet-to-lymphocyte Ratio is Associated with In-hospital Mortality in Critically Ill Patients with Acute Kidney Injury Requiring Continuous Renal Replacement Therapy  ÀüÀ¯Çö(°æºÏ´ëº´¿ø) 
±³À°½Ã°£ 05-26 Room 4(3F) 09:00~09:10 Comparison of Incidence of Acute Kidney Injury, Chronic Kidney Disease and End-stage Renal Disease Between Atrial Fibrillation and Atrial Flutter: The Good, the Bad, the Ugly  Wei Syun Hu(CMUH) 
±³À°½Ã°£ 05-26 Room 4(3F) 09:10~09:20 The Effects of Sarcopenia on Mortality of Patients with Acute Kidney Injury Requiring Continuous Renal Replacement Therapy  ÀÌÀå¿í(µ¿±¹´ëÀϻ꺴¿ø) 
±³À°½Ã°£ 05-26 Room 4(3F) 09:20~09:30 Initial Emergency Room-6 Hours Urine Volume is an Important Factor for Critically Ill Patient  ÇѼöÇö(Ãæ³²´ëÇб³º´¿ø) 
±³À°½Ã°£ 05-26 Room 4(3F) 09:30~09:40 Urinary Cytokines/Chemokines for Differential Diagnosis of Acute Interstitial Nephritis and Acute Tubular Necrosis  ¹é¼ÛÀÎ(¸íÁö´ëº´¿ø) 
±³À°½Ã°£ 05-26 Room 4(3F) 09:40~09:50 Tamsulosin Mediate Ureter Smooth Muscle Contraction by Increasing Potassium Current: An In-Silico Study  Chitaranjan Mahapatra(University of California San Francisco) 
±³À°½Ã°£ 05-26 Room 4(3F) 09:50~10:00 Impact of Timing and Stage of Acute Kidney Injury on Clinical Outcome in Patients with Covid-19  ±è¼º±Ù(¼­¿ïÀÇ´ë) 
±³À°½Ã°£ 05-26 Room 4(3F) 10:00~10:10 Early Versus Standard Initiation of Continuous Renal Replacement Therapy(CRRT) In Patients Undergoing Aortic Surgery  ¾çÀºÁö(¿¬¼¼ÀÇ´ë °­³²¼¼ºê¶õ½ºº´¿ø) 
±³À°½Ã°£ 05-26 Room 4(3F) 10:10~10:20 Glucosylated Albumin Ameliorates Kidney Injury Through Improvement of Mitochondrial Function  ¾ÈÁ¤³²(ÇѸ²´ëÇб³¼º½Éº´¿ø) 
±³À°½Ã°£ 05-26 Room 4(3F) 10:20~10:30 The Role of the Circadian Clock System in the Transition Acute Kidney Injury to Chronic Kidney Disease  ¹æÀ̳ª(°í·Á´ëÇб³¾È¾Ïº´¿ø) 
±³À°½Ã°£ 05-26 Room 4(3F) 10:40~10:50 Impact of Metabolic Acidosis on All-Cause Mortality in Patients With COVID-19  ±è¿¹¸²(°è¸íÀÇ´ë) 
±³À°½Ã°£ 05-26 Room 4(3F) 10:50~11:00 Airborne Particulate Matter Exposure Induces Renal Tubular Cell Injury in Vitro: The Role of Vitamin D Signaling and the Renin Angiotensin System  ÀÓÇüÀº(°í·Á´ëÇб³¾È»êº´¿ø) 
±³À°½Ã°£ 05-26 Room 4(3F) 11:00~11:10 The Risk of Depression, Suicidal Plan, and Suicidal Attempt in Chronic Kidney Disease: Results From the Korean National Health and Nutrition Examination Survey 2013-2018  ¼Û°¡¿µ(¿øÁÖ¼¼ºê¶õ½ºº´¿ø) 
±³À°½Ã°£ 05-26 Room 4(3F) 11:10~11:20 Anti-inflammatory Effects of Zeaxanthin in Pulmonary Artery Hypertension Model of Rat  Rahul Kumar(J K College) 
±³À°½Ã°£ 05-26 Room 4(3F) 11:20~11:30 Use of Angiotensin Receptor Neprilysin Inhibitor in End Stage Renal Disease Patients With Reduced Cardiac Ejection Fraction: Real-World Experience From a Single Center  °íÇöÁø(ÀÇÈ­ÀÇ´ë¸ñµ¿º´¿ø) 
±³À°½Ã°£ 05-26 Room 4(3F) 11:30~11:40 Cellular Senescence in Perirenal Adipose Tissue Is Associated With Exacerbation of Renal Ischemia-Reperfusion Injury in Diet-Induced Obese Mice  ±è¼­¸°(¾ç»êºÎ»ê´ëº´¿ø) 
±³À°½Ã°£ 05-26 Room 4(3F) 11:40~11:50 Association of Nocturnal Heart Rate Dipping With Nocturnal Systolic Blood Pressure Dipping During Pre-living Kidney Donation Period  Ekamol Tantisattamo(University of California Irvine School of Medicine) 
±³À°½Ã°£ 05-26 Room 4(3F) 11:50~12:00 Antibiotics-Induced Intestinal Microbiota Depletion Can Attenuate Acute Kidney Injury Transition to Chronic Kidney Disease in Mice Unilateral Ischemia-Reperfusion Injury Model  ÀÌÁ¤È¯(¼­¿ïƯº°½Ãº¸¶ó¸Åº´¿ø) 
±³À°½Ã°£ 05-26 Room 4(3F) 12:00~12:10 Study of Vitamin D Levels, Vascular Risk Factors and Inflammation in Type 2 Diabetic Patients  Vikas Sharma(Sarojini Naidu Medical College) 
±³À°½Ã°£ 05-26 Room 4(3F) 12:10~12:20 Development and Validation of Deep Learning Algorithm for Detecting Hyperkalemia Based on Electrocardiogram  ¾ÈÁ¤³²(ÇѸ²´ëÇб³¼º½Éº´¿ø) 
±³À°½Ã°£ 05-26 Room 4(3F) 12:20~12:30 Anti-atherosclerotic Effects of Cinnamon Bark Extract in Cholesterol Diet Induced Hyperlipidemia in Rats  Rohit Kumar(Memorial Institute of Engineering and Technology) 
±³À°½Ã°£ 05-26 Room 4(3F) 13:40~13:50 Deep Learning-Based Prediction Model for Prognosis of IgA Nephropathy  ¹Ú¼¼ÈÆ(¼­¿ï´ëº´¿ø) 
±³À°½Ã°£ 05-26 Room 4(3F) 13:50~14:00 The Difference of Activation Pattern of Complement System Between Pediatric and Adult Lupus Nephritis  ¹Ú¹ÎÁö(°æºÏ´ëº´¿ø) 
±³À°½Ã°£ 05-26 Room 4(3F) 14:00~14:10 Higher IL-12 and IL-23 Levels and Increased P-Glycoprotein Expression Drive the Transition of Th17 Cells to Pathogenic IFN-* Producing Th17 Cells in Refractory Nephrotic Syndrome  Akhilesh Jaiswal(Sanjay Gandhi Post Graduate Institute of Medical Sciences) 
±³À°½Ã°£ 05-26 Room 4(3F) 14:10~14:20 Proteomic Analysis of Exosomes From Human Tubular Epithelial Cells With Suppressed TG2 Activity Under Fibrotic Injury  ±è±ÔÇö(¼­¿ï´ëº´¿ø) 
±³À°½Ã°£ 05-26 Room 4(3F) 14:20~14:30 Genetic Variants in MIR3142HG Contribute to the Predisposition of IgA Nephropathy in a Chinese Han Population  JiaLi Wei(Hainan Affiliated Hospital of Hainan Medical University) 
±³À°½Ã°£ 05-26 Room 4(3F) 14:30~14:40 Inhibition of RNA Methylation Signaling Pathway Mediated by METTL3 Attenuates Kidney Fibrosis  ÀÌÁ¤È¯(¼­¿ïƯº°½Ãº¸¶ó¸Åº´¿ø) 
±³À°½Ã°£ 05-26 Room 4(3F) 14:40~14:50 Monocyte-Derived Circulating Microparticles and Glomerular M2 Macrophage Infiltration in IgAN  Snigdha Singh(SANJAY GANDHI POST GRADUATE INSTITUTE OF MEDICAL SCIENCES) 
±³À°½Ã°£ 05-26 Room 4(3F) 14:50~15:00 Cystamine Inhibits TGF¥â Induced Changes in Podocytes Using Metabolomic Analysis  ¹®Á¾ÁÖ(¼­¿ï´ëÇб³ »ý¹°ÀÇÇבּ¸¼Ò) 
±³À°½Ã°£ 05-26 Room 4(3F) 15:10~15:20 Potential of Tc-99m Sestamibi Dynamic Renal Scan and Quantitative SPECT/CT for the Evaluation of Renal Mitochondrial Dysfunction: A Preliminary Study  ¹Ú¼öºó(¼øõÇâ´ëÇб³º´¿ø) 
±³À°½Ã°£ 05-26 Room 4(3F) 15:20~15:30 Long Noncoding RNA FGD5-AS1 Sponges MicroRNA-497-5p to Regulate Hyperuricaemia-Induced Renal Interstitial Fibrosis in a Rat Model Involving LIM Domain Only 7  JiaLi Wei(Hainan Affiliated Hospital of Hainan Medical University) 
±³À°½Ã°£ 05-26 Room 4(3F) 15:30~15:40 The Effects of 12 Weeks Contact-Free Combined Exercise Program on Health Fitness, Quality of Life, Physical Activity and Kidney Function in Pediatric Patients With Chronic Kidney Disease  ÀÌÇöÁÖ(¼­¿ï´ëº´¿ø) 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" ´ëÇѽÅÀåÇÐȸ KSN(Korea Society of Nephrology) 2022 (1ÀÏÂ÷) : 2022-05-26""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û (¿Â¶óÀÎ) ±¹¸³¾Ï¼¾ÅÍ ¾Ï°úÇÐÆ÷·³, Ç׾Ͻžళ¹ß A-Z, Part 4. mRNA vaccine: from COVID-19 to Cancer : 2022-05-27
´ÙÀ½±Û ´ëÇѽŻý¾ÆÇÐȸ [¿Â¶óÀÎ] ÃæûÁöȸ Áý´ãȸ : 2022-05-26
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20467 ¼­¿ï 2024 ´ëÇÑÇ÷¾×ÇÐȸ Á¶Á÷±¸Áõ½ÄÁõ¿¬±¸È¸ ½ÉÆ÷Áö¾ö : 2024-05-31 0 77 2024-04-17
20466 °æ±â ¾ÆÁִ뺴¿ø ÀÀ±ÞÀÇÇаú ¼³¸³ 30Áֳ⠱â³ä ½ÉÆ÷Áö¿ò : 2024-05-30 0 40 2024-04-17
20465 ¼­¿ï Á¦20Â÷ ´ëÇѸð¹ßÇÐȸ Çмú´ëȸ ÇÁ·Î±×·¥ : 2024-05-26 0 47 2024-04-17
20464 °æ±â 2024³â Á¦86Â÷ ´ëÇÑ»ý½ÄÀÇÇÐȸ Ãá°èÇмú´ëȸ : 2024-05-26 0 36 2024-04-17
20463 ¼­¿ï 2024³â ´ëÇѼҾƼÒÈ­±â¿µ¾çÇÐȸ Ãá°è ½ÉÆ÷Áö¾ö : 2024-05-26 0 27 2024-04-17
20462 ¼­¿ï ´ëÇÑÃæ°ÝÆÄÄ¡·áÇÐȸ 2024 Ãá°è Çмú´ëȸ : 2024-05-26 0 27 2024-04-17
20461 ¼­¿ï Áø´Ü ü°èÀû¹®Çå°íÂû ¿öÅ©¼¥ : 2024-05-25 0 30 2024-04-17
20460 ¼­¿ï ´ëÇѺñ¸¸ÇÐȸ Á¦17ȸ ODOT (One Day Course of Obesity Treatment) : 2024-05-25 0 24 2024-04-17
20459 ¼­¿ï 2024³â Á¾¾ç¸é¿ª´ÙÇÐÁ¦¿¬±¸È¸ Ãá°è½ÉÆ÷Áö¾ö : 2024-05-24 0 16 2024-04-17
20458 ¼­¿ï 2024 Á¦12ȸ ´ëÇÑÇ÷¾×ÇÐȸ Ç÷¿ìº´¿¬±¸È¸ ½ÉÆ÷Áö¾ö : 2024-05-24 0 29 2024-04-17
20457 ¼­¿ï 2024³â ¿µµîÆ÷±¸ÀÇ»çȸ Ãá°è Çмú´ëȸ : 2024-05-21 0 32 2024-04-17
20456 ¼­¿ï 2024³â ´ëÇÑÀÓ»ó°Ç°­ÁõÁøÇÐȸ Ãá°èÇмú´ëȸ ¹× ¿¬¼ö°­Á : 2024-05-19 0 35 2024-04-17
20455 ¼­¿ï Á¦7Â÷ ´ëÇѼö¸éÈ£ÈíÇÐȸ Ãá°èÇмú´ëȸ : 2024-05-19 0 41 2024-04-17
20454 ¼­¿ï 2024 ´ëÇѼҾÆÇ÷¾×Á¾¾çÇÐȸ Ãá°è¿¬¼ö°­Á : 2024-05-18 0 26 2024-04-17
20453 ¼­¿ï 2024³â ´ëÇÑ¿¬ÇÏÀå¾ÖÇÐȸ Á¦14ȸ Ãá°èÇмú´ëȸ : 2024-05-18 0 31 2024-04-17
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷